CARTERS INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $CRI in the last 7 days.
No SEC Form 4 filings for $CRI in the last 30 days.
See all $CRI insider activity →Needham maintained a Hold rating on Carter's (NYSE:CRI) but lowered its earnings estimates for fiscal 2026 and 2027, citing demand challenges, inflation, and weather. The firm reduced Q3 2026 EPS estimate to $0.80 from $0.85. Carter's trades at a P/E of 6.08, with analysts divided on its outlook. UBS lowered its price target to $38, while BMO initiated coverage with a $40 target and an Outperform rating.
Carter's Q3 results and Q4 guidance could lead to significant share price movements, according to UBS Securities. UBS also adjusted its price target for Carter's to $38 from $41, maintaining a neutral rating. The company's shares were trading at $32.06, up 1.92% on the day.
UBS reduced its price target for Carter's (NYSE:CRI) to $38 from $41, citing margin concerns due to higher oil and cotton prices. The firm maintained a Neutral rating, noting the stock's low P/E ratio and high short interest. Carter's recently reported Q2 2026 earnings of $0.26 per share on $615M revenue, beating estimates, but shares fell due to margin pressure concerns. BMO Capital initiated coverage with an Outperform rating and $40 price target.
Recent CRI coverage spans earnings, financial news and market movers.
Analyst estimate cuts suggest near‑term earnings pressure for Carter's.
The downgrade suggests analysts see weaker near‑term performance, likely pressuring the share price.
Target cut suggests downside pressure on the stock.
The preview suggests modest growth; traders may position ahead of the release.
Brand reinvention plus margin compression and tariff headwinds could keep investors focused on execution and pricing power.
AlphAI scores every news story that mentions CRI with an AI model for sentiment and relevance, and aggregates insider trades from CARTERS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Needham maintained a Hold rating on Carter's (NYSE:CRI) but lowered its earnings estimates for fiscal 2026 and 2027, citing demand challenges, inflation, and weather. The firm reduced Q3 2026 EPS estimate to $0.80 from $0.85. Carter's trades at a P/E of 6.08, with analysts divided on its outlook. UBS lowered its price target to $38, while BMO initiated coverage with a $40 target and an Outperform rating.
2 min readCarter's Q3 results and Q4 guidance could lead to significant share price movements, according to UBS Securities. UBS also adjusted its price target for Carter's to $38 from $41, maintaining a neutral rating. The company's shares were trading at $32.06, up 1.92% on the day.
1 min readUBS reduced its price target for Carter's (NYSE:CRI) to $38 from $41, citing margin concerns due to higher oil and cotton prices. The firm maintained a Neutral rating, noting the stock's low P/E ratio and high short interest. Carter's recently reported Q2 2026 earnings of $0.26 per share on $615M revenue, beating estimates, but shares fell due to margin pressure concerns. BMO Capital initiated coverage with an Outperform rating and $40 price target.
2 min readCarter's, Inc. (CRI) will release Q3'26 earnings on October 23. Analysts expect revenue of 751.49M USD and EPS of 0.88 USD. The announcement is scheduled for 8:00 AM ET.
1 min readCarter's, a 161-year-old children's clothing brand, is undergoing its most significant rebranding in 26 years to remain relevant. The company reported $2.898 billion in net sales for fiscal 2025, with a declining operating margin. It faces economic pressures and changing parenting trends, aiming to balance heritage with modern needs.
7 min readCarter's (CRI) stock fell 1% after Wells Fargo analyst Ike Boruchow cut his price target to $30 from $42, maintaining an equal weight rating. The move follows Q2 earnings that beat estimates but included a $132M one-time government payment, and missed Q3 guidance. The company has seen declining sales and thin profitability in recent years.
2 min readG-III (GIII) raised full-year guidance but underperformed estimates, with shares down 16.2%. Figs (FIGS) reported 28.8% revenue growth, beating estimates, and shares rose 24.3%. Stitch Fix (SFIX) missed EBITDA estimates, with shares down 4.3%. Carter's (CRI) beat revenue expectations but missed guidance, shares down 14.6%. Under Armour (UAA) reported a 3.2% revenue decline, shares down 24.4%.
3 min readCarter's (CRI) stock fell 15.4% post-earnings, trading at $31.98. Figs (FIGS) reported 28.8% revenue growth, beating estimates, with stock up 21.2% at $13.62. Stitch Fix (SFIX) missed EBITDA estimates, stock down 5.9% at $2.66. ThredUp (TDUP) met revenue expectations but missed guidance, stock down 65.8% at $2.15. Oxford Industries (OXM) reported a 2.2% revenue decline, stock down 30.7% at $25.39.
2 min readBMO Capital initiated coverage on Carter’s Inc. (NYSE:CRI) with an outperform rating and a $40.00 price target. The firm expects benefits from new leadership, improved wholesale mix, and lower tariffs. CRI trades at $32.28, with a P/E ratio of 6.06, and analysts anticipate earnings growth. The company recently reported Q2 2026 earnings of $0.26 per share, beating estimates, but faces wholesale demand challenges and margin pressures.
1 min readCarter's Inc. (CRI) reported a 5% year-over-year increase in net sales and a 54% jump in adjusted operating profit for Q2 fiscal 2026. The company's U.S. Retail business saw a 5% rise in comparable sales, driven by strong demand in baby products and e-commerce growth. Management highlighted strategic investments and improved execution, while noting challenges like tariff uncertainty and cautious consumer spending. CRI shares have risen 21.2% in the past year, trading at a forward P/E of 10.13X.
2 min read
